Calls for Proposals FY 2024 e-ASIA Joint Research Program (e-ASIA JRP) – Joint Call for “Health Research”

In Japanese

Change log

03/21/2024　The template of "Application Form 1J2J" was updated. Please note that the reference number is "6-1" instead of "5-2" in 6-2. (Submission using an older version is also possible).

Outline

Status of Grants/Funding Opportunities	Grants/Funding Opportunities
R&D phase	Basic Study, Applied Study, Nonclinical Study/Pre-clinical Study, Clinical Study, Clinical Trials
Key Fields	Innovation and Clinical Research Center Project, Infectious disease
Submission Deadline	03/29/24 Fri
Contact	Division of International Program, Department of International Strategy E-mail: e-asia "at" amed.go.jp, Replace "at" with "@". Remarks: Please contact us, preferably by e-mail using the above contact information.

Public offering content

The Japan Agency for Medical Research and Development (AMED) is pleased to announce a call for proposals for FY 2024 e-ASIA Joint Research Program (e-ASIA JRP) in the fields of “Health Research“ as shown below.

#	Research area	Project size (excluding indirect costs)	Research period	Number of projects to be selected
1	Infectious Diseases and Immunology (including Antimicrobial Resistance)	Up to 7.5 million yen per year for each project	36 months Jan. 2025-Dec. 2027	0-3 projects

Research area

Project size
(excluding indirect costs)

Research period

Number of projects to be selected

Infectious Diseases and Immunology (including Antimicrobial Resistance)

Up to 7.5 million yen per year for each project

36 months

Jan. 2025-Dec. 2027

0-3 projects

Note: The project size and the number of projects to be selected may change depending on the budget situation. For details, please refer to the English version of the Application Guideline and the supplementary application notes for Japan-based researchers.

Program summary

The e-ASIA Joint Research Program (hereinafter referred to as the “e-ASIA JRP”) aims to develop a vibrant and collaborative research community in Science and Technology, to promote innovation in ASEAN region, and to contribute to the region’s economic development. As part of the program, the following Member Organizations of the e-ASIA JRP have agreed to implement a joint call for proposals of multilateral cooperative research activities.

Participating Member Organizations (listed in alphabetical order):

Anstralia: National Health and Medical Reseach Council (NHMRC)
Indonesia: National Research and Innovation Agency (BRIN)
Japan: Japan Agency for Medical Research and Development (AMED)
Lao PDR: Ministry of Health (MOH)
Philippines: Department of Science and Technology (DOST-PCHRD)
Singapore: Agency for Science, Technology and Research (A*STAR)
United States of America: National Institute of Allergy and Infectious Diseases (NIAID)

Aim of Joint Call and Research Area

The aim of the joint call is not only to contribute to the development of regional science but also to overcome public health and medical problems in ASEAN countries through multilateral collaboration. The e-ASIA JRP 13th CAll in the field of Health Research is to invite applications that will address the health impacts in Southeast Asian countries specifically focus on Infectious Diseases and Immunology (including Antimicrobial Resistance) research area.

Program Details

The e-ASIA Joint Research Program (e-ASIA JRP)

Eligibility

Japan-based applicants

Please refer Application Guideline I. Eligibility for Japan-based applicants.

Solicitation Period

12/15/23 Fri - 03/29/24 Fri

Lead PI must submit Proposals by e-mail to the e-ASIA JRP Secretariat by 17:00 (Thai Standard Time, UTC+7) on 29th March 2024.

　Yukio Kemmochi, PhD (Mr.)
　e-ASIA JRP Secretariat
　E-mail: easia_secretariat"at"jst.go.jp, Replace "at" with "@".

Japan-based applicants must also submit a project title, a summary of the project, and detailed budget information in Japanese with the application forms (Form 1J2J) through the online application system, “e-Rad”, by 17:00 (Japanese Standard Time, UTC+9) on 29th March 2024.